Mucinous breast carcinomas lack PIK3CA and AKT1 mutations-Reference-Cited by-同舟云学术

Mucinous breast carcinomas lack PIK3CA and AKT1 mutations

Published:2012-12 Issue:12 Volume:43 Page:2207-2212
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Kehr Elizabeth L.,Jorns Julie M.,Ang Daphne,Warrick Andrea,Neff Tanaya,Degnin Michelle,Lewis Rebecca,Beadling Carol,Corless Christopher L.,Troxell Megan L.

Funder

Susan G. Komen for the Cure

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference28 articles.

1. Mutation of the PIK3CA oncogene in human cancers;Karakas;Br J Cancer,2006

2. The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer;Castaneda;Cancer Metastasis Rev,2010

3. Targeting PI3K signalling in cancer: opportunities, challenges and limitations;Engelman;Nat Rev Cancer,2009

4. PIK3CA/AKT1 mutations in breast carcinoma: a comprehensive review of experimental and clinical studies;Troxell;J Clinic Experiment Pathol,2012

5. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics;Hennessy;Cancer Res,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Classification of Breast Cancer;PET Clinics;2023-10

2. Biomarkers in Breast Carcinomas;Biomarkers in Carcinoma of Unknown Primary;2022

3. Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine;Pharmacogenomics and Personalized Medicine;2021-11

4. Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer;Clinical Breast Cancer;2021-06

5. The genomic landscape of carcinomas with mucinous differentiation;Scientific Reports;2021-05-04